Faeth Therapeutics, Inc. (FTH)
8.50
-0.19
(-2.19%)
USD |
NASDAQ |
Nov 20, 12:23
Faeth Therapeutics Cash from Investing (Quarterly) : 0.175M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.175M |
| June 30, 2026 | -108.07M |
| March 31, 2026 | -31.44M |
| December 31, 2025 | 2.081M |
| September 30, 2025 | 1.743M |
| June 30, 2025 | 8.757M |
| March 31, 2025 | 7.191M |
| December 31, 2024 | -3.151M |
| September 30, 2024 | 12.91M |
| June 30, 2024 | 6.907M |
| March 31, 2024 | 5.77M |
| December 31, 2023 | 8.262M |
| September 30, 2023 | 8.312M |
| June 30, 2023 | 19.53M |
| Date | Value |
|---|---|
| March 31, 2023 | 2.312M |
| December 31, 2022 | 16.04M |
| September 30, 2022 | 8.517M |
| June 30, 2022 | 13.20M |
| March 31, 2022 | 12.19M |
| December 31, 2021 | 5.612M |
| September 30, 2021 | -0.482M |
| June 30, 2021 | -147.76M |
| March 31, 2021 | -0.487M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -0.199M |
| March 31, 2020 | -0.052M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | -6.00M |
| Zymeworks, Inc. | -386.22M |
| Rhythm Pharmaceuticals, Inc. | -16.11M |
| Cue Biopharma, Inc. | 0.00 |
| Yarrow Bioscience, Inc. | -5.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.00M |
| Cash from Financing (Quarterly) | 0.104M |
| Free Cash Flow | -43.28M |
| Free Cash Flow Per Share (Quarterly) | -0.5033 |
| Free Cash Flow to Equity (Quarterly) | -12.56M |
| Free Cash Flow to Firm (Quarterly) | -13.00M |
| Free Cash Flow Yield | -19.70% |